Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

6.97
Delayed Data
As of 4:00pm ET
 +0.02 / +0.29%
Today’s Change
1.42
Today|||52-Week Range
8.09
+89.40%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a -21.09% decrease from the last price of 6.97.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.20
Sales
$3.3M
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.50%
 
 
 
 
 
 
Growthannually -57.45%
 
 
 
 
 
 

Sales

Growthquarterly -5.37%
 
 
 
 
 
 
Growthannually -68.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.